Skip to main content
. 2021 Nov 1;9:611652. doi: 10.3389/fpubh.2021.611652

Table 3.

The prevalence % (CI) of different comorbidities in normal, pre-diabetes, and undiagnosed and diagnosed diabetes, community-based cohort study (KERCADR−2nd Phase-N = 9,959), Kerman, Iran, 2014–2018.

Comorbidities (PHASE2) Normal Pre-DM Undiagnosed DM Diagnosed DM
Hypertension 22.1 (21.2–23.1) 35.6 (33.1–38.1) 44.7 (38.9–50.5) 61.0 (58.4–63.6)
Hypercholesterolemia 14.1 (13.3–15.0) 26.6 (24.3–28.9) 40.5 (34.8–46.2) 55.4 (52.8–58.1)
Hypertriglyceridemia 30.3 (29.2–31.3) 46.0 (43.4–48.6) 61.8 (56.2–67.5) 70.3 (67.9–72.7)
Depression 15.9 (15.0–16.7) 13.7 (11.9–15.5) 10.1 (6.6–13.6) 20.4 (18.3–22.6)
Anxiety 40.6 (39.4–41.7) 39.2 (36.6–41.7) 35.6 (30.1–41.2) 46.1 (43.4–48.7)
Overweight and obesity 59.4 (58.2–60.5) 75.9 (73.6–78.1) 83.5 (79.2–87.8) 77.3 (75.1–79.5)

CI, confidence interval; DM, diabetes mellitus; pre-DM, pre-diabetes.